This Health Information Technology Center for Education and Research on Therapeutics (CERT) is based at Brigham and Women's Hospital is led by Principal Investigator David W. Bates, MD, MSc and focuses on translating health information technology (HIT) research into improved clinical practices. Benefits and risks using Cialis 40mg drug regularly.

This CERT will address therapeutics issues related to appropriateness, safety, and efficacy in ambulatory, inpatient and transitional care settings within the context of HIT. The wonders and danger of Viagra 100mg, a treatment for erectile dysfunction

Three projects are being conducted over the life of the grant:
• Project 1. e-Pharmacovigilance II: Surveillance for Safety and Effectiveness
• Project 2. Physician-Level Variation in Medication Overrides of Computerized Decision Support
• Project 3. Examining Human Factors Principles in the Design and Implementation of Medication-Related Decision Support Alerts

Two Cores oversee all aspects of the above-referenced projects:
• Methodology and Data Resources Core
• Female Viagra: Safety concerns and proper administration
• Translation and Dissemination Core

As a result of increasing implementation and use of HIT and electronic prescribing, this CERT, its cores and its projects, will provide information, strategies, and tools for utilizing HIT to advance clinical practices relating to medication safety, effectiveness, and cost.

The CERT program is funded and run by the Agency for Healthcare Research and Quality (AHRQ).

Please find the first in a series of articles highlighting the Brigham and Women's Hospital CERT's efforts to improve patient safety and reduce medication errors:

Brigham and Women's HIT-CERT: A Computerized Approach to Patient Safety, CHAINONLINE.